Navigation Links
Wound Management Technologies, Inc. Announces Conference Plans and Clinical Data Presentation at Leading Diabetic Foot Conference

FORT WORTH, Texas, March 15 /PRNewswire-FirstCall/ -- (OTC Bulletin Board: WNDM) Wound Management Technologies, Inc., a growing  provider of specialty medical products, announced today that its subsidiary Wound Care Innovations will exhibit at the DFCon 10 Global Diabetic Foot Conference in Los Angeles March 18-20.  Expected attendance is more than 1000 physicians, clinicians, researchers, scientists, and limb salvage experts from all 50 U.S. states and more than 42 foreign countries.  An evidence based study using their advanced wound care collagen product, CellerateRx®,  "Activated Collagen Accelerates Wound Repair and Modulates Cytokine Production in Whole Blood and PBMC Cultures" by Greg Pott, PhD, K.Scott Beard, PhD, Matthew Regulski, DPM, and Leland Shapiro, MD is one of the accepted abstracts presented at the conference.

"We are delighted to once again participate in this important conference," states Cathy Bradshaw, President of Wound Care Innovations.  "Diabetic wounds continue to be one of the most serious issues we face in health care today. Diabetes affects 24 million people in the U.S. and 189 million people worldwide and up to 25% of those will develop a foot ulcer.  We are excited about the outcomes we have seen with CellerateRx® in addressing these difficult wounds, and about the important clinical data presentation this year."

CellerateRx® patented advanced wound care collagen products are FDA cleared for all acute and chronic wounds except 3rd degree burns.

For Wound Management Technologies Shareholder Information please call 561-515-6035 or go to

About Wound Care Innovations, LLC

Wound Care Innovations, LLC (WCI) is a wholly owned subsidiary of Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) with its corporate headquarters in Fort Worth, Texas, and regional offices in Ft. Lauderdale, Florida. WCI markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products.  For more information on CellerateRx, please visit the WCI website at .

About Wound Management Technologies, Inc.

Wound Management Technologies Inc's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, in the $3.2B worldwide advanced wound care market, a market that is growing due to aging populations and the increase of diabetes.  Over the past 2 years WMT has focused on developing evidenced-based studies on CellerateRX and gaining physician awareness by participation in key industry conferences. Now WMT is focused on expanding sales through partnerships and contracted independent representatives. WMT has other advanced biotech products in development for bone wax, bone void fillers and shingles pain reduction as well as a subsidiary focused on eHealth technology for secure healthcare data collaboration and storage.  More information can be found on the company's websites:, , and .

Safe Harbor Statement:

The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Further Information:

Shareholder Relations-Communications    561-515-6035

SOURCE Wound Management Technologies, Inc.

Back to top



SOURCE Wound Management Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Healing Wounds and Hearts: Warrior Weekend Helps Soldiers and Marines Relax and Recover
2. A novel in vitro model for light-induced wound healing
3. Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit
4. Wound-Healing Maggots Succumb to Deadly Bacteria
5. Wounded Warrior Project and Operation Touchdown 2010 Join Forces for Super Bowl XLIV
6. Wound treatment wins commercialization funds
7. Avery Dennison Innovates in Consumer Wound Care
8. LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes
9. Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup
10. Wounded Warrior Project (WWP) Applauds the Senate for Passing Crucial Family Caregiver Legislation
11. Wake Pharma US, Inc. Announces the Appointment of Kim Eldridge as Coordinator & Clinical Wound Specialist Educator
Post Your Comments:
(Date:11/25/2015)... ... 2015 , ... The holiday season is jam-packed with family ... of attendees is of the utmost importance. Whether you are cooking at home ... recipes a try this holiday season. , Turkey Croquettes ,     Ingredients: ...
(Date:11/25/2015)... ... 2015 , ... Ministers, senior government and UN agencies, representatives ... of Excellence, and public R&D institutions, civil societies and other partners gathered today ... African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day ...
(Date:11/25/2015)... ... 25, 2015 , ... Dental professionals who would like to become more proficient ... attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held ... the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens ... Bruxism, and moderate facial wrinkling. While many patients are aware of the benefits of ... success Botox® delivers to those suffering with discomfort, soreness, and pain as a result ...
(Date:11/25/2015)... , ... November 25, 2015 , ... “While riding the ... inventor, from Bronx, N.Y. “I thought there had to be a convenient and comfortable ... PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during cold or inclement ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ... kidney transplantation is expected to boost the market growth, as ... transplantation. --> 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... Research and Markets ( ) has ... Market by Type (Dressings, Therapy Devices, Active Wound Care), ... Facility), and Geography - Global Forecast to 2020" ... --> The purpose of this report ... the global advanced wound care market. It involves deep ...
Breaking Medicine Technology: